Quick Takeaways
- Skorpios Trust filed SCHEDULE 13D/A for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK).
- Disclosed ownership: 4.1%.
- Date of event: 22 Aug 2025.
Skorpios Trust - 22 Aug 2025 SCHEDULE 13D/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)
- Filing Manager
- Skorpios Trust
- Reporting Manager
- Montrago Trustees Ltd
- Symbol
- STOK
- Shares outstanding
- 55,028,805 shares
- Disclosed Ownership
- 2,256,181 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13D/A
- Filing time
- 26 Aug 2025, 17:42:26 UTC
- Date of event
- 22 Aug 2025
- Previous filing
- 23 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Skorpios Trust disclosed 4.1% ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK) on 22 Aug 2025."
What Changed
- Previous schedule filing date: 23 Jun 2025.
- Current filing was accepted on 26 Aug 2025, 17:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Blue Horizon Enterprise Ltd | 3.6% | 1,967,621 | 0 | 1,967,621 | /s/ Eleni Constantinou Kyriacou | Eleni Constantinou Kyriacou, Director | 0001869057 |
| Ezbon International Ltd | 0.5% | 288,560 | 0 | 288,560 | /s/ Eleni Constantinou Kyriacou | Eleni Constantinou Kyriacou, Director | 0001869027 |
| Montrago Trustees Ltd | 4.1% | 2,256,181 | 0 | 2,256,181 | /s/ Androulla Papadopoulou | Androulla Papadopoulou, Director | 0001869331 |
| Skorpios Trust | 4.1% | 2,256,181 | 0 | 2,256,181 | /s/ Androulla Papadopoulou | Androulla Papadopoulou, Director | 0001869333 |